Search Within

Jacob Lowell Glass

Formats
  1. Meeting Abstract (27)
  2. Journal Article (22)
  3. Book Section (3)
  4. Editorial (2)
  5. Correspondence (1)
  6. Research Letter (1)
Groups
  1. Adult Leukemia (56)
  2. Center for Hematologic Malignancies (56)
  3. Department of Medicine (56)
  4. Hematologic Malignancies, Division of (56)
  5. GSK Faculty (41)
  6. Human Oncology and Pathogenesis Program (39)

More Groups

People
  1. Ross Levine (37)
  2. Martin Tallman (27)
  3. Christopher Famulare (24)
  4. Wenbin Xiao (22)
  5. Mikhail Roshal (21)
  6. Aaron Goldberg (18)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (4)
  5. 2021 (8)
  6. 2020 (7)

More Years

Publications
  1. Blood (25)
  2. Cancer Discovery (7)
  3. Blood Advances (3)
  4. Pocket Oncology (3)
  5. American Journal of Hematology (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. American Association for Cancer Research (9)
  3. Nature Publishing Group (4)
  4. Wolters Kluwer Health | Lippincott Williams & Wilkins (3)
  5. Elsevier Ltd (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival
    Meeting Abstract

    Ahr, K.; Famulare, C.; Koche, R.; Spitzer, B.; Levine, R. L.; Tallman, M. S.; Goldberg, A. D.; Stein, E. M.; Glass, J. L.
    Blood (2018)

    Fulltext@MSK | Save
  • Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis
    Journal Article

    Pronier, E.; Bowman, R. L.; Ahn, J.; Glass, J.; Kandoth, C.; Merlinsky, T. R.; Whitfield, J. T.; Durham, B. H.; Gruet, A.; Hanasoge Somasundara, A. V.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Genetically-defined AML subgroups represent diverse epigenetic heterogeneity landscape
    Meeting Abstract

    Li, S.; Chen, X.; Wang, J.; Meydan, C.; Glass, J. L.; Shih, A. H.; Valk, P. J. M.; Delwel, R.; Levine, R. L.; Mason, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Lineage deconvolution using chromatin accessibility and DNA methylation shows a spectrum of lineage characteristics and differentiation states across acute leukemias
    Meeting Abstract

    Glass, J. L.; Palia, A. J.; Garrett-Bakelman, F. E.; Koche, R.; Levine, R. L.; Tallman, M. S.; Dillon, R. J.; Grimwade, D.; Ferrando, A. A.; Valk, P. J. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers
    Journal Article

    Glass, J. L.; Hassane, D.; Wouters, B. J.; Kunimoto, H.; Avellino, R.; Garrett-Bakelman, F. E.; Guryanova, O. A.; Bowman, R.; Redlich, S.; Intlekofer, A. M.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells
    Journal Article

    Vu, L. P.; Prieto, C.; Amin, E. M.; Chhangawala, S.; Krivtsov, A.; Calvo-Vidal, M. N.; Chou, T.; Chow, A.; Minuesa, G.; Park, S. M.; more...
    Nature Genetics (2017)

    Fulltext@MSK | Save
  • Combination targeted therapy to disrupt aberrant oncogenic signaling and reverse epigenetic dysfunction in IDH2- and TET2-mutant acute myeloid leukemia
    Journal Article

    Shih, A. H.; Meydan, C.; Shank, K.; Garrett-Bakelman, F. E.; Ward, P. S.; Intlekofer, A. M.; Nazir, A.; Stein, E. M.; Knapp, K.; Glass, J.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save